135 related articles for article (PubMed ID: 38456221)
1. Factors associated with venom immunotherapy side-effects, re-sting reactions, and adherence in real-life.
Parke L; Kjaer HF; Halken S; Bindslev-Jensen C; Mortz CG
Clin Exp Allergy; 2024 May; 54(5):359-361. PubMed ID: 38456221
[No Abstract] [Full Text] [Related]
2. Venom immunotherapy for preventing allergic reactions to insect stings.
Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
[TBL] [Abstract][Full Text] [Related]
3. Hymenoptera Venom Allergy: Re-Sting reactions.
Mesquita AM; Carneiro-Leão L; Amaral L; Coimbra A
Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):94-96. PubMed ID: 32548996
[No Abstract] [Full Text] [Related]
4. The value of immunotherapy with venom in children with allergy to insect stings.
Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
[TBL] [Abstract][Full Text] [Related]
5. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
7. Venom immunotherapy: pitfalls and open questions.
Aberer W; Sturm G
Immunotherapy; 2011 Nov; 3(11):1277-9. PubMed ID: 22053877
[No Abstract] [Full Text] [Related]
8. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
9. Hymenoptera venom immunotherapy and field stings.
Lang R; Hawranek T
J Investig Allergol Clin Immunol; 2006; 16(4):224-31. PubMed ID: 16889279
[TBL] [Abstract][Full Text] [Related]
10. Anaphylaxis from insect stings. Myths, controversy, and reality.
Settipane GA; Boyd GK
Postgrad Med; 1989 Aug; 86(2):273-6, 278, 280-1. PubMed ID: 2666971
[TBL] [Abstract][Full Text] [Related]
11. Adverse reactions to venom immunotherapy.
Ramirez DA; Londono S; Evans R
Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
Stritzke AI; Eng PA
Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
[TBL] [Abstract][Full Text] [Related]
13. Management of insect sting hypersensitivity.
Li JT; Yunginger JW
Mayo Clin Proc; 1992 Feb; 67(2):188-94. PubMed ID: 1545581
[TBL] [Abstract][Full Text] [Related]
14. Basophil sensitivity in patients not responding to venom immunotherapy.
Peternelj A; Silar M; Erzen R; Kosnik M; Korosec P
Int Arch Allergy Immunol; 2008; 146(3):248-54. PubMed ID: 18270492
[TBL] [Abstract][Full Text] [Related]
15. [Standardized rapid hyposensitization with purified hymenoptera venom in wasp venom allergy. Prospective study of development of tolerance and side-effect profile].
Treudler R; Tebbe B; Orfanos CE
Hautarzt; 1997 Oct; 48(10):734-9. PubMed ID: 9441166
[TBL] [Abstract][Full Text] [Related]
16. Further observations of stopping venom immunotherapy: comparison of patients stopped because of a fall in serum venom-specific IgE to insignificant levels with patients stopped prematurely by self-choice.
Reisman RE; Lantner R
J Allergy Clin Immunol; 1989 Jun; 83(6):1049-54. PubMed ID: 2732405
[TBL] [Abstract][Full Text] [Related]
17. Deliberate bee sting challenge of patients receiving maintenance venom immunotherapy at 3-month intervals.
Goldberg A; Confino-Cohen R; Mekori YA
J Allergy Clin Immunol; 1994 Jun; 93(6):997-1001. PubMed ID: 8006322
[TBL] [Abstract][Full Text] [Related]
18. Depot extracts for rush venom immunotherapy: A new therapeutic opportunity for Hymenoptera sting allergy.
Pucci S; Ciccarelli F; De Pasquale T; Illuminati I; D'Alò S
Ann Allergy Asthma Immunol; 2018 Sep; 121(3):376-377. PubMed ID: 29908318
[No Abstract] [Full Text] [Related]
19. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
[TBL] [Abstract][Full Text] [Related]
20. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
Lange J; Cichocka-Jarosz E; Marczak H; Krauze A; Tarczoń I; Świebocka E; Lis G; Brzyski P; Nowak-Węgrzyn A
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):225-9. PubMed ID: 26945496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
